ArticleInterdisciplinary sciences, computational life sciences2026
NeuroPpred-MSN: A Neuropeptide Prediction Model Based on Multi-feature Fusion and Siamese Networks.
Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The discovery of neuropeptides offers numerous opportunities for identifying novel drugs and targets to treat a variety of diseases. While various computational methods have been proposed, there remains potential for further performance improvement. In this work, we introduce NeuroPpred-MSN, an innovative and efficient neuropeptide prediction model that leverages multi-feature fusion and Siamese networks. To comprehensively represent the information of neuropeptides, the peptide sequences are encoded by four encoding schemes (token embedding, word2vec embedding, protein language embedding, and handcrafted features). Then, the token embedding and word2vector embedding are fed to a Siamese network channel. In the other channel of the model, peptide sequences and their secondary structure sequences are fed into ProtT5-XL-UniRef50 model to generate the embedding features, while handcrafted encoding techniques are used to extract the physicochemical information. Then the two kinds of features are fused and fed into a bidirectional gated recurrent unit (Bi-GRU) network for further processing. Ultimately, the outputs of the two channels are integrated into a fully connected layer, thereby facilitating the generation of the final prediction. The results on the independent test set indicate that NeuroPpred-MSN exhibits superior predictive performance, with an area under the receiver operating characteristic curve (AUROC) of 98.3%, exceeding the performance of other state-of-the-art predictors. Specifically, compared to other optimal results, this model exhibits improvements of 1.52% in accuracy (ACC), 1.52% in F1 score (F1), 3.2% in Matthews correlation coefficient (MCC), and 1.55% in AUROC. The model was further evaluated on imbalanced datasets, where it achieved the highest values in AUROC, ACC, MCC, sensitivity (SN), and F1, further demonstrating its robustness and generalization. The model can be accessed at the following GitHub repository: https://github.com/wenjean/NeuroPpred-MSN .
Indexed as
Identifiers
40459710What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.